SOPHiA GENETICS to Announce Financial Results for the Second Quarter of Fiscal 2022 on August 9, 2022

Jul 14 2022
BOSTON and LAUSANNE, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a leader in data-driven medicine, today announced it will release its financial results for the second quarter of fiscal 2022 before U.S. markets open on Tuesday, August 9, 2022.

Read more

Build something bigger than your career

Enjoyed learning about life at SOPHiA from our blogs? Here are a few of our open roles

Title Country Department
Junior Sales Operations Specialist Intern France Clinical Sales
Junior Bioinformation Intern - Tertiary Analysis Switzerland Data Science
Junior Customer Services Specialist Intern Switzerland Clinical Sales
Accounts Payable Accountant France Finance
NGS Sales Manager - ANZ Australia Clinical Sales